title: CD34+ cell mobilization and upregulation of myocardial cytokines in a rabbit model of myocardial ischemia.
abstract: BACKGROUND
  Studies have suggested that myocardial infarction may induce bone marrow stem cell mobilization and homing to the infarcted area, contributing to myocardial repair and tissue regeneration. Despite some encouraging results using stem cell therapy for myocardial regeneration in humans and animals, the mechanisms behind this activity remain unclear. In this study, we investigate stem cell mobilization and homing in ischemic myocardium, and investigate the involvement of cytokines TNFα and VEGF in this process.
  
  
  RESULTS
  Myocardial ischemia models were created by partial ligation of the left anterior descending coronary artery in Japanese white male rabbits. Immunohistochemistry analysis of ischemic myocardium showed the presence of VEGF and TNFα along with homing of CD34 positive (CD34+) cells to the region in the 7 days following surgery. During the same period, an increase in percentage of CD34+ cells in peripheral blood and in VEGF and TNFα mRNA expression in ischemic tissue was observed in animals that underwent partial LAD ligation. Terminal dUTP nick end-labeling (TUNEL) showed that cell apoptosis in the ischemic myocardium decreased between days 7 and 28 following surgery. None of these changes were observed in animals that underwent sham operation.
  
  
  CONCLUSIONS
  In the early stages of myocardial ischemia, bone marrow stem cells are mobilized and home to ischemic myocardium with a concomitant increase in expression of cytokines VEGF and TNFα. Furthermore, cell apoptosis occurs in the ischemic myocardium, possibly due to the activity of TNFα which is thought to induce cardiomyocyte apoptosis.
authors.affiliation: Department of Cardiology, The First Affiliated Hospital of Medical College in Xi'an Jiaotong University, Xi'an, Shaanxi 710061, China. zhaoqingbin05@163.com
authors.forename: Qingbin
authors.initials: Q
authors.lastname: Zhao
authors.forename: Chaofeng
authors.initials: C
authors.lastname: Sun
authors.forename: Xin
authors.initials: X
authors.lastname: Xu
authors.forename: Juan
authors.initials: J
authors.lastname: Zhou
authors.forename: Yue
authors.initials: Y
authors.lastname: Wu
authors.forename: Yuling
authors.initials: Y
authors.lastname: Tian
authors.forename: Zuyi
authors.initials: Z
authors.lastname: Yuan
authors.forename: Zhiquan
authors.initials: Z
authors.lastname: Liu
mesh_terms: D000818:Animals; D018952:Antigens, CD34 / Q000378:metabolism; D017209:Apoptosis / Q000502:physiology; D001854:Bone Marrow Cells / Q000166:cytology* / Q000378:metabolism; D002465:Cell Movement / Q000502:physiology*; D004195:Disease Models, Animal; D006412:Hematopoietic Stem Cells / Q000166:cytology* / Q000378:metabolism; D008297:Male; D017202:Myocardial Ischemia / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology*; D009206:Myocardium / Q000378:metabolism / Q000473:pathology; D012333:RNA, Messenger / Q000378:metabolism; D011817:Rabbits; D014409:Tumor Necrosis Factor-alpha / Q000235:genetics / Q000378:metabolism*; D015854:Up-Regulation / Q000502:physiology; D042461:Vascular Endothelial Growth Factor A / Q000235:genetics / Q000378:metabolism*
chemical_list: D018952:Antigens, CD34; D012333:RNA, Messenger; D014409:Tumor Necrosis Factor-alpha; D042461:Vascular Endothelial Growth Factor A